Differentiating Diabetic Ketoacidosis and Hyperglycemic Ketosis Due to Cannabis Hyperemesis Syndrome in Adults With Type 1 Diabetes
Deng Y, Tu H, Pierzynski JA, Miller ED, Gu X, Huang M, Chang DW, Ye Y, Hildebrandt MAT , Klein AP, Zhao R, Lippman SM, Wu X
These SCFAs not only nourishes colon cells and reduces inflammation, but also stimulates GLP-1 secretion via G-protein-coupled receptors
Generation of Slc25a39 KO and conditional KO mice All animal studies and procedures were conducted according to a protocol approved by the Institutional Animal Care and Use Committee (IACUC) at the Rockefeller University
Choose your wellness goal Explore focused wellness options built around how you want to look, feel, and perform
GLP-1 drugs reduce glucagon levels, preventing unnecessary glucose release